Currently, urine Albuminuria-to-Creatinine Ratio (UACR) and estimation of GFR (eGFR) does not have the sensitivity and specificity for early prediction of diabetic kidney disease(DKD) in type 2 diabetic patient (T2DP). Thus, both UACR and eGFR are unfit for DKD management.
Taken from: Nonalbuminuric vs albuminuric diabetic kidney disease in type 2 diabetes: A systematic review and meta-analysis. Front Endocrinol, 13, 871272.
What is DNlite-DKD?
DNlite-DKD is an in-vitro diagnostic test approved by Healthy Science Authority (HSA) that measures unique biomarker found in urine.
What is it used for ?
It is used in conjunction with clinical evaluation as an aid in assessing the prognosis of kidney function in type 2 diabetes patients with albuminuria.
For more information , click here.
For publications related to DNlite-DKD:
DNlite-IVD103, a novel urinary test, predicts progressive eGFR decline in type 2 diabetes with microalbuminuria. Kidney International Reports.
Association of urinary DNlite-IVD103 with CKD and coronary artery disease in diabetic patients. Journal of the American Society of Nephrology.
Urinary fetuin-A fragments predict progressive estimated glomerular filtration rate decline in type 2 diabetes with microalbuminuria. American Journal of Nephrology.
